Rio-Vilariño, A., Cenigaonandia-Campillo, A., García-Bautista, A., Mateos-Gómez, P. A., Schlaepfer, M. I., Puerto-Nevado, L. d., . . . Cebrián, A. (2024). Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Citación estilo ChicagoRio-Vilariño, Anxo, et al. Inhibition of the AURKA/YAP1 Axis Is a Promising Therapeutic Option for Overcoming Cetuximab Resistance in Colorectal Cancer Stem Cells. 2024.
Cita MLARio-Vilariño, Anxo, et al. Inhibition of the AURKA/YAP1 Axis Is a Promising Therapeutic Option for Overcoming Cetuximab Resistance in Colorectal Cancer Stem Cells. 2024.
Precaución: Estas citas no son 100% exactas.